Abstract
Gene expression of 5-lipoxygenase (5-LO) and leukotriene A4 (LTA4) hydrolase was analyzed in the peripheral blood of 48 children with active primary nephrotic syndrome (PNS) (group I), 27 children with PNS in remission (group II), and 20 controls. Group I included 34 patients with steroid-sensitive PNS (SSNS) and 14 patients with steroid-resistant PNS (SRNS). Total RNA purified from peripheral blood mononuclear (PBMN) cells was reverse transcribed into cDNA and amplified with specific primers in the polymerase chain reaction. All group I patients and none of the controls expressed 5-LO and LTA4 hydrolase. Of group II children, 22.2% expressed 5-LO, while 51.9% expressed LTA4 hydrolase. Among group I patients there was a significant positive correlation between the degree of proteinuria and the expression of 5-LO (r=0.27, P=0.03) and LTA4 hydrolase (r=0.44, P=0.001). There was no difference in the degree of expression of both enzymes between SSNS and SRNS patients. In conclusion, leukotrienes may play a role in the pathogenesis of PNS in children, but they do not participate in the response of these patients to steroids.
Similar content being viewed by others
References
Samuelsson B, Dahlen SE, Lindgren JA, Rouzer CA, Serhan CN (1987) Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 237:1171–1176
Henderson WR (1994) The role of leukotrienes in inflammation. Ann Intern Med 121:684–697
Lewis RA, Austen KF, Soberman RJ (1991) Leukotrienes and other products of the 5-lipoxygenase pathway. N Engl J Med 323:645–652
Badr KF (1991) Arachidonic acid metabolites in glomerular injury. Semin Nephrol 11:332–339
Dixon RAF, Jones RE, Diehl R, Bennett CD, Kargman S, Rouzer CA (1988) Cloning of the cDNA for human 5-lipoxygenase. Proc Nat Acad Sci USA 85:416–420
International Study of Kidney Disease in Children (ISKDC) (1981) The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. J Pediatr 98:561–564
Menegatti E, Roccatello D, Hadden K, Piccoli G, De Rosa G, Sena LM, Rifai A (1999) Gene expression of 5-lipoxygenase and LTA4 hydrolase in renal tissue of nephrotic syndrome patients. Clin Exp Immunol 116:347–353
Shindo M, Mullin GE, Braun-Elwert L, Bergasa NV, Jones EA James SP (1996) Cytokine mRNA expression in the liver of patients with primary biliary cirrhosis (PBC) and chronic hepatitis B (CHB). Clin Exp Immunol 105:254–259
Badr KF (1997) Glomerulonephritis: roles for lipoxygenase pathways in pathophysiology and therapy. Curr Opin Hypertens Nephrol 6:111–118
Brady HR, O’Meara YM (1997) Lipoxins, leukocyte recruitment and the resolution phase of acute glomerulonephritis. Kidney Int [Suppl] 58:56–61
Nassar GM, Badr KF (1995) Role of leukotrienes and lipoxygenases in glomerular injury. Miner Electrolyte Metab 21:262–270
Brady HR, Serhan CN (1992) Adhesion promotes transcellular leukotriene biosynthesis during neutrophils-glomerular endothelial cell interactions: inhibition by antibodies against CD18 andl-selectin. Biochem Biophys Res Commun 186:1307–1314
Rifai A, Sakai H, Yagame M (1993) Expression of 5-lipoxygenase and 5-lipoxygenase activation protein in glomerulonephritis. Kidney Int 43 [Suppl 39]:S95–S99
Lianos EA (1988) Synthesis of hydroxyeicosatetraenoic acids leukotrienes in rat nephrotoxic serum glomerulonephritis. Role of anti-glomerular basement membrane antibody dose, complement, and neutrophils. J Clin Invest 82:427–435
Rahman MA, Nakazawa M, Emancipator SN, Dunn MJ (1988) Increased leukotriene B4 synthesis in immune injured rat glomeruli. J Clin Invest 81:1945–1952
Lefkowith JB, Nagamatsu T, Pippin J, Schreiner JF (1991) Role of leukocytes in metabolic and functional derangements of experimental glomerulonephritis. Am J Physiol 261:F213–F220
Petric R, Ford-Hutchison AW (1994) Elevated cysteinyl leukotriene excretion in experimental glomerulonephritis. Kidney Int 46:1322–1329
Petric R, Ford-Hutchinson AW (1995) Inhibition of leukotriene biosynthesis improves renal function in experimental glomerulonephritis. J Lipid Med 11:231–240
Valdivielso JM, Montero A, Badr KF, Munger KA (2003) Inhibition of 5-lipoxygenase activating protein decreases proteinuria in diabetic rats. J Nephrol 16:85–94
Guasch A, Zayas CF, Badr KF (1999) MK-591 acutely restores glomerular size selectivity and reduces proteinuria in human glomerulonephritis. Kidney Int 56:261–267
Serhan CN (1997) Lipoxins and novel aspirin-triggered 15-epi-lipoxins: a jungle of cell-cell interactions or a therapeutic opportunity. Prostaglandins 53:107–137
Wenzel SE (1997) Arachidonic acid metabolites: mediators of inflammation in asthma. Pharmacotherapy 17:35–125
Albrightson CR, Short B, Dytko G, Zabko-Potapovich B, Brickson B, Adams JL, Griswold DE (1994) Selective inhibition of 5-lipoxygenase attenuates glomerulonephritis in the rat. Kidney Int 45:1301–1310
Takahashi K, Kato T, Schreiner GF, Ebert J, Badr KF (1992) Essential fatty acid deficiency normalizes function and histology in rat nephrotoxic serum nephritis. Kidney Int 41:1245–1253
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bakr, A., Hawas, S., Slem, S. et al. 5-Lipoxygenase and leukotriene A4 hydrolase expression in primary nephrotic syndrome. Pediatr Nephrol 19, 396–399 (2004). https://doi.org/10.1007/s00467-003-1399-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-003-1399-3